Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

US Food and Drug Administration Support for Oncology Drug Development During COVID-19

US Food and Drug Administration Support for Oncology Drug Development During COVID-19 This Viewpoint seeks to contextualize recent US Food and Drug Administration guidance on clinical trials during COVID-19 to oncology and to share insight regarding regulatory challenges and lessons learned. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

US Food and Drug Administration Support for Oncology Drug Development During COVID-19

JAMA Oncology , Volume 7 (1) – Jan 8, 2021

Loading next page...
 
/lp/american-medical-association/us-food-and-drug-administration-support-for-oncology-drug-development-5hGY7SHT00
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2020.4975
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint seeks to contextualize recent US Food and Drug Administration guidance on clinical trials during COVID-19 to oncology and to share insight regarding regulatory challenges and lessons learned.

Journal

JAMA OncologyAmerican Medical Association

Published: Jan 8, 2021

References